Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein

Infection and Immunity

Volumn 70, Issue 7, 2002, Pages 3324-3329

  Bhattacharjee, Apurba K ^a   Van De Verg, Lillian ^a   Izadjoo, Mina J ^a   Yuan, Liang ^a   Hadfield, Ted L ^a   Zollinger, Wendell D ^a   Hoover, David L ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BRUCELLA VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; BRUCELLA MELITENSIS; BRUCELLOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; IMMUNIZATION; LUNG INFECTION; LUNG LAVAGE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN DISEASE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BRUCELLA MELITENSIS; BRUCELLOSIS; FEMALE; LIPOPOLYSACCHARIDES; LIVER; LUNG; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS; SPLEEN; VACCINATION;

EID: 0036081163     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.7.3324-3329.2002     Document Type: Article

References (37)

1. Molecular characterization of Brucella strains isolated from marine mammals
2. Structural elucidation of the Brucella melitensis antigen by high resolution NMR at 500 MHz
3. Structure of the O-chain of the phenol-phase soluble cellular lipopolysaccharide of Yersinia enterocolitica serotype 0:9
4. Killing of Brucella abortus by bovine serum
5. Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers
6. Colorimetric method for determination of sugars and related substances
7. Isolation of three Brucella abortus cell-wall antigens protective in murine experimental brucellosis
8. Antibody-mediated protection against Brucella abortus in Balb/c mice at successive periods after infection: Variation between virulent strain 2308 and attenuated vaccine strain 19
9. Enzyme-linked immunosorbent assay. ELISA III. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes
10. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes
11. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines
12. In vitro markers and biological activity in mice of seed lot strains and commercial Brucella melitensis Rev 1 and Brucella abortus B19 vaccines
13. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201 (16M deltapurEK)
14. Impaired control of Brucella melitensis infection in Rag1-deficient mice
15. Induction of antibody and protective responses in mice by Brucella O-polysaccharide-BSA conjugate
16. Improved techniques for the preparation of bacterial lipopolysaccharides
17. Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon -activated murine peritoneal macrophages
18. Influence of endotoxin-protein in immunoglobulin G isotype responses of mice to Brucella abortus lipopolysaccharide
19. Brucella bacteremia: Clinical and laboratory observations in 160 patients
20. Bacteriological and histopathological features of a mouse model for intranasal Brucella melitensis infection
21. Comparison of living and non-living vaccines for Brucella abortus in Balb/c mice
22. Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide
23. The nature of human brucellosis in Kwait: Study of 379 cases
24. Resistance against a subcutaneous Brucella challenge of mice immunized with living or dead Brucella or by transfer of immune serum
25. Killed vaccine in adjuvant and protection of mice against an intraperitoneal challenge of Brucella: Kinetic studies
26. Resistance of Brucella abortus infected mice to intravenous or intraperitoneal Brucella infection
27. Carrier-mediated enhancement of cognate T cell help: The basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine
28. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen
29. Immune serum-mediated effects on brucellosis evolution in mice
30. Immunity to Brucella abortus induced in mice by popliteal lymph node restricted strain 19 vaccination
31. Immunogenicity of Brucella -extracted and recombinant protein vaccines in CD-1 and BALB/c mice
32. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice
33. Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models
34. Effectiveness of natural and synthetic complexes of porin and O-polysaccharide as vaccine against Brucella abortus in mice
35. An overview of human brucellosis
36. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man